Samuela ‘Ofanoa, PhD, from the University of Auckland in New Zealand, and colleagues examined what types of gout content are on TikTok and assessed their association with user engagement. The analysis ...
In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, ...
Gout, a painful joint condition, is on the rise globally, affecting even younger individuals. This surge is linked to ageing ...
Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...
SOBI has agreed to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly potent and ...
The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...
For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II ...
Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...
Australian sprint sensation Gout Gout returns to Golden Spike Ostrava 2026 alongside Greek pole vaulter Emmanouil Karalis and ...
Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi ...
The form of arthritis causes severe pain and swelling in the big toes, feet, wrists and ankles, and affects about 1.5 million ...
Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectorySTOCKHOLM, Dec. 13, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback